FCC ID 2AA4P-ARX2006
Zalviso Sufentanil Sublingual Tablet System
by AcelRx Pharmaceuticals Inc.
Grantee Code: 2AA4P Product Code: ARX2006
Latest application date: 2019-02-21
FCC ID Device Details
| FCC ID | 2AA4P-ARX2006 |
|---|---|
| Mirrors | fcc.id | gov | fccid.ai |
| Grantee Code | 2AA4P |
| Product Code | ARX2006 |
| Applicant Business | AcelRx Pharmaceuticals Inc. 🇺🇸 |
| Related Domains |  acelrx.com |
| Equipment Class | Zalviso Sufentanil Sublingual Tablet System |
| Test Firm | IntertekTesting Services NA Inc. |
Operating Frequencies
| Frequency Range | Application Purpose | Final Action Date |
|---|---|---|
| 13.56 MHz | Original Equipment | 2019-02-21 |
Exhibits
| Document | Type | Available | File |
|---|---|---|---|
| Manual 1/4 | Users Manual | 2019-02-21 | PDF 4.9 MB |
| Manual 2/4 | Users Manual | 2019-02-21 | PDF 4.8 MB |
| Manual 3/4 | Users Manual | 2019-02-21 | PDF 4.9 MB |
| Manual 4/4 | Users Manual | 2019-02-21 | PDF 4.3 MB |
| Internal photos | Internal Photos | 2019-02-21 | PDF 801.2 KB |
| External photos | External Photos | 2019-02-21 | PDF 310.6 KB |
| Label location | ID Label/Location Info | 2019-02-21 | PDF 62.2 KB |
| Label sample | ID Label/Location Info | 2019-02-21 | PDF 155.1 KB |
| Test setup photos | Test Setup Photos | 2019-02-21 | PDF 717.3 KB |
| Test report | Test Report | 2019-02-21 | PDF 1.4 MB |
| Confidentiality request | Cover Letter(s) | 2019-02-21 | PDF 418.6 KB |
| Block diagram Metadata only | Block Diagram | PDF 58.3 KB | |
| schematics Metadata only | Schematics | PDF 250 KB | |
| Operational description Metadata only | Operational Description | PDF 551.4 KB |
Application Information
| Application ID | ajDotDfk3q/a0LJabqe1Kw== |
|---|---|
| Final Action Date | 2019-02-21 |
| Application Purpose | Original Equipment |
| Applicant FRN | 0017240185 |
| Model | ARX2006 |
| Frequency Range | 13.56 MHz |
| Equipment Class | DXT - Part 15 Low Power Transceiver, Rx Verified |
| Device Description | Zalviso Sufentanil Sublingual Tablet System |
| Responsible Party | Al Landas, Director, Electrical & Software Engineering, alandas@acelrx.com , 6502163521 |
| Technical Contact | Al Landas, AcelRx Pharmaceuticals Inc., alandas@acelrx.com , 6502163521 |
| Non-Technical Contact | Al Landas, AcelRx Pharmaceuticals Inc., alandas@acelrx.com , 6502163521 |
| Test Firm | Charles Parker, IntertekTesting Services NA Inc., charles.parker@intertek.com  , 650-463-2900 |
| TCB Email | tcb_admin@intertek.com |
| TCB Scope | A1: Low Power Transmitters below 1 GHz (except Spread Spectrum), Unintentional Radiators, EAS (Part 11) & Consumer ISM devices |
| Short-Term Confidentiality | No |
| Long-Term Confidentiality | Yes |
| Grant Deferral | No |
| Modular Equipment | Does not apply |
| Composite Device | No |
| Composite Part | No |
| Cognitive Radio | No |
| Authorization Waiver | No |
| Authorization Waiver Approved | No |
| Section 5301 Certification | Yes |
| Related OET Knowledge DataBase Inquiry | No |
Applications
| Application ID | Date | Purpose |
|---|---|---|
| ajDotDfk3q/a0LJabqe1Kw== | 2019-02-21 | Original Equipment |
Equipment Authorization
| Frequency | Rules |
|---|---|
| 13.56 MHz | 15C |
Grants
TCB Grant - Application ajDotDfk3q/a0LJabqe1Kw==
| TCB | GRANT OF EQUIPMENT AUTHORIZATION |
TCB |
| Certification | ||
| Issued Under the Authority of the | ||
| Federal Communications Commission | ||
| By: |
|
Intertek Testing Services NA, Inc. 70 Codman Hill Road Boxborough, MA 01719 |
Date of Grant: 02/21/2019 Application Dated: 02/21/2019 |
| AcelRx Pharmaceuticals Inc. |
| 351 Galveston Drive |
| Redwood City, CA 94063 |
| Attention: Al Landas , Director, Electrical & Software Engineering |
| NOT TRANSFERABLE |
| EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below. |
| FCC IDENTIFIER: | 2AA4P-ARX2006 |
| Name of Grantee: | AcelRx Pharmaceuticals Inc. |
| Equipment Class: | Part 15 Low Power Transceiver, Rx Verified |
| Notes: | Zalviso Sufentanil Sublingual Tablet System |
| Grant Notes | FCC Rule Parts | Frequency Range (MHZ) | Output Watts | Frequency Tolerance | Emission Designator |
| 15C | 13.56 - 13.56 |
EAS Grant - Application ajDotDfk3q/a0LJabqe1Kw==
| COPY |
FEDERAL COMMUNICATIONS COMMISSION WASHINGTON, D.C. 20554 GRANT OF EQUIPMENT AUTHORIZATION |
COPY |
| Certification |
|
AcelRx Pharmaceuticals Inc. 351 Galveston Drive Redwood City, CA 94063 United States |
Date of Grant: 02/21/2019 Application Dated: 02/21/2019 |
| Attention: Al Landas , Director, Electrical & Software Engineering |
| NOT TRANSFERABLE |
| EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below. |
| FCC IDENTIFIER: | 2AA4P-ARX2006 |
| Name of Grantee: | AcelRx Pharmaceuticals Inc. |
| Equipment Class: | Part 15 Low Power Transceiver, Rx Verified |
| Notes: | Zalviso Sufentanil Sublingual Tablet System |
| Modular Type: | Does not apply |
| Grant Notes | FCC Rule Parts | Frequency Range (MHZ) | Output Watts | Frequency Tolerance | Emission Designator |
| 15C | 13.56 - 13.56 |
| Mail To: |